Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001514649 | SCV001722549 | benign | DICER1-related tumor predisposition | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001702601 | SCV002068601 | benign | not specified | 2022-01-11 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001702601 | SCV002551517 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002329651 | SCV002631530 | benign | Hereditary cancer-predisposing syndrome | 2019-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Department of Pathology and Laboratory Medicine, |
RCV005400506 | SCV006055347 | benign | Euthyroid goiter; Rhabdomyosarcoma, embryonal, 2; Pleuropulmonary blastoma; Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529704 | SCV001743615 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001702601 | SCV001928397 | benign | not specified | no assertion criteria provided | clinical testing |